Table 2.
Quality assessment of included human studies by PEDro.
| Study | Eligiblety criteria | Random allocation | Concealed allocation | Baseline comparability | Blind subjects | Blind therapists | Blind assessors | Adequate follow-up | Intention-to-treat analysis | Between group comparisons | Point estimates and variability | Total scores |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lipsman et al 2018 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 7/11 |
| Meng et al 2019 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 8/11 |
| Beisteiner et al 2019 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 7/11 |
| Nicodemus et al 2019 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 6/11 |
| Meng et al 2019 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 4/11 |
| Rezai et al 2020 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 7/11 |